StockData
Teladoc Health, Inc. logo

Teladoc Health, Inc. (TDOC) stock

TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3041% below fair value
$8.49−0.21 (-2.41%)

Close on Nov 17, 2026Market cap $1.55BP/E –Yield –

Teladoc Health r&d expenses

Research and development expenses are spending on new products and technology.

Teladoc Health's R&D Expenses for the twelve months ending Sep 30, 2026 was $267.88M, down 5.4% year over year. For fiscal 2025 it was $277.92M, down 9.6% from the year before. Over ten years it grew 34.6% a year on average. The highest annual figure on record is $348.52M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$277.92M-9.6%
FY2024Dec 31, 2024$307.27M-11.8%
FY2023Dec 31, 2023$348.52M+4.5%
FY2022Dec 31, 2022$333.63M+7.0%
FY2021Dec 31, 2021$311.88M+89.1%
FY2020Dec 31, 2020$164.94M+155.2%
FY2019Dec 31, 2019$64.64M+18.9%
FY2018Dec 31, 2018$54.37M+57.8%
FY2017Dec 31, 2017$34.46M+58.0%
FY2016Dec 31, 2016$21.82M+53.5%
FY2015Dec 31, 2015$14.21M+87.6%
FY2014Dec 31, 2014$7.57M+114.4%
FY2013Dec 31, 2013$3.53M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$65.55M-3.0%
Q2 FY2026Jun 30, 2026$62.86M-8.6%
Q1 FY2026Mar 31, 2026$67.87M-3.0%
Q4 FY2025Dec 31, 2025$71.61M-6.7%
Q3 FY2025Sep 30, 2025$67.57M-6.6%
Q2 FY2025Jun 30, 2025$68.78M-10.4%
Q1 FY2025Mar 31, 2025$69.96M-14.0%
Q4 FY2024Dec 31, 2024$76.75M-14.7%
Q3 FY2024Sep 30, 2024$72.38M-14.1%
Q2 FY2024Jun 30, 2024$76.75M-12.1%
Q1 FY2024Mar 31, 2024$81.39M-6.4%
Q4 FY2023Dec 31, 2023$89.94M+8.4%
Q3 FY2023Sep 30, 2023$84.29M-0.4%
Q2 FY2023Jun 30, 2023$87.31M+10.9%
Q1 FY2023Mar 31, 2023$86.99M-0.5%
Q4 FY2022Dec 31, 2022$82.93M+13.8%
Q3 FY2022Sep 30, 2022$84.59M+5.4%
Q2 FY2022Jun 30, 2022$78.70M-2.6%
Q1 FY2022Mar 31, 2022$87.41M+12.1%
Q4 FY2021Dec 31, 2021$72.87M-21.4%
Q3 FY2021Sep 30, 2021$80.25M+167.9%
Q2 FY2021Jun 30, 2021$80.76M+250.7%
Q1 FY2021Mar 31, 2021$78.01M+305.1%
Q4 FY2020Dec 31, 2020$92.70M+470.6%
Q3 FY2020Sep 30, 2020$29.96M+90.3%
Q2 FY2020Jun 30, 2020$23.03M+38.2%
Q1 FY2020Mar 31, 2020$19.26M+20.5%
Q4 FY2019Dec 31, 2019$16.25M+19.9%
Q3 FY2019Sep 30, 2019$15.75M+16.0%
Q2 FY2019Jun 30, 2019$16.67M+16.1%
Q1 FY2019Mar 31, 2019$15.99M+23.9%
Q4 FY2018Dec 31, 2018$13.54M+29.7%
Q3 FY2018Sep 30, 2018$13.58M+36.3%
Q2 FY2018Jun 30, 2018$14.35M+90.4%
Q1 FY2018Mar 31, 2018$12.90M+98.2%
Q4 FY2017Dec 31, 2017$10.45M+77.2%
Q3 FY2017Sep 30, 2017$9.96M–
Q2 FY2017Jun 30, 2017$7.54M–
Q1 FY2017Mar 31, 2017$6.51M–
Q4 FY2016Dec 31, 2016$5.89M–

More Teladoc Health figures

See a number that looks wrong?